[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Peripheral Intervention Drug-Eluting Devices Consumption Market Report

October 2018 | 137 pages | ID: 2991B791712EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Peripheral Intervention Drug-Eluting Devices market for 2018-2023.
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.

Over the next five years, LPI(LP Information) projects that Peripheral Intervention Drug-Eluting Devices will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Intervention Drug-Eluting Devices market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Plain Old Balloon Angioplasty (POBA)
  • Percutaneous Transluminal Angioplasty (PTA)
Segmentation by application:
  • Drug-Eluting Balloons
  • Drug-Eluting Stents
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Spain
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Cardinal Health
  • B. Braun Melsungen AG
  • Biosensors International Group Ltd.
  • C.R. Bard, Inc.
  • St. Jude Medical, Inc.
  • The Lubrizol Corporation
  • Terumo Corporation
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES
  • To study and analyze the global Peripheral Intervention Drug-Eluting Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Peripheral Intervention Drug-Eluting Devices market by identifying its various subsegments.
  • Focuses on the key global Peripheral Intervention Drug-Eluting Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Peripheral Intervention Drug-Eluting Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Peripheral Intervention Drug-Eluting Devices submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 GLOBAL PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Peripheral Intervention Drug-Eluting Devices Consumption 2013-2023
  2.1.2 Peripheral Intervention Drug-Eluting Devices Consumption CAGR by Region
2.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
  2.2.1 Plain Old Balloon Angioplasty (POBA)
  2.2.2 Percutaneous Transluminal Angioplasty (PTA)
2.3 Peripheral Intervention Drug-Eluting Devices Consumption by Type
  2.3.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type (2013-2018)
  2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Type (2013-2018)
2.4 Peripheral Intervention Drug-Eluting Devices Segment by Application
  2.4.1 Drug-Eluting Balloons
  2.4.2 Drug-Eluting Stents
2.5 Peripheral Intervention Drug-Eluting Devices Consumption by Application
  2.5.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2013-2018)
  2.5.2 Global Peripheral Intervention Drug-Eluting Devices Value and Market Share by Application (2013-2018)
  2.5.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Application (2013-2018)

3 GLOBAL PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY PLAYERS

3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Players
  3.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Players (2016-2018)
  3.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Players (2016-2018)
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Players
  3.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Players (2016-2018)
  3.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Players (2016-2018)
3.3 Global Peripheral Intervention Drug-Eluting Devices Sale Price by Players
3.4 Global Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Peripheral Intervention Drug-Eluting Devices Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES BY REGIONS

4.1 Peripheral Intervention Drug-Eluting Devices by Regions
  4.1.1 Global Peripheral Intervention Drug-Eluting Devices Consumption by Regions
  4.1.2 Global Peripheral Intervention Drug-Eluting Devices Value by Regions
4.2 Americas Peripheral Intervention Drug-Eluting Devices Consumption Growth
4.3 APAC Peripheral Intervention Drug-Eluting Devices Consumption Growth
4.4 Europe Peripheral Intervention Drug-Eluting Devices Consumption Growth
4.5 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Growth

5 AMERICAS

5.1 Americas Peripheral Intervention Drug-Eluting Devices Consumption by Countries
  5.1.1 Americas Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018)
  5.1.2 Americas Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018)
5.2 Americas Peripheral Intervention Drug-Eluting Devices Consumption by Type
5.3 Americas Peripheral Intervention Drug-Eluting Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Peripheral Intervention Drug-Eluting Devices Consumption by Countries
  6.1.1 APAC Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018)
  6.1.2 APAC Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018)
6.2 APAC Peripheral Intervention Drug-Eluting Devices Consumption by Type
6.3 APAC Peripheral Intervention Drug-Eluting Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Peripheral Intervention Drug-Eluting Devices by Countries
  7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018)
  7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018)
7.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Type
7.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices by Countries
  8.1.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018)
8.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption by Type
8.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Peripheral Intervention Drug-Eluting Devices Distributors
10.3 Peripheral Intervention Drug-Eluting Devices Customer

11 GLOBAL PERIPHERAL INTERVENTION DRUG-ELUTING DEVICES MARKET FORECAST

11.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast (2018-2023)
11.2 Global Peripheral Intervention Drug-Eluting Devices Forecast by Regions
  11.2.1 Global Peripheral Intervention Drug-Eluting Devices Forecast by Regions (2018-2023)
  11.2.2 Global Peripheral Intervention Drug-Eluting Devices Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Peripheral Intervention Drug-Eluting Devices Forecast by Type
11.8 Global Peripheral Intervention Drug-Eluting Devices Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Medtronic plc
  12.1.1 Company Details
  12.1.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Medtronic plc News
12.2 Boston Scientific Corporation
  12.2.1 Company Details
  12.2.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Boston Scientific Corporation News
12.3 Abbott Laboratories
  12.3.1 Company Details
  12.3.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Abbott Laboratories News
12.4 Cardinal Health
  12.4.1 Company Details
  12.4.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Cardinal Health News
12.5 B. Braun Melsungen AG
  12.5.1 Company Details
  12.5.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 B. Braun Melsungen AG News
12.6 Biosensors International Group Ltd.
  12.6.1 Company Details
  12.6.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Biosensors International Group Ltd. News
12.7 C.R. Bard, Inc.
  12.7.1 Company Details
  12.7.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 C.R. Bard, Inc. News
12.8 St. Jude Medical, Inc.
  12.8.1 Company Details
  12.8.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.8.3 St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 St. Jude Medical, Inc. News
12.9 The Lubrizol Corporation
  12.9.1 Company Details
  12.9.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 The Lubrizol Corporation News
12.10 Terumo Corporation
  12.10.1 Company Details
  12.10.2 Peripheral Intervention Drug-Eluting Devices Product Offered
  12.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Terumo Corporation News

13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Peripheral Intervention Drug-Eluting Devices
Table Product Specifications of Peripheral Intervention Drug-Eluting Devices
Figure Peripheral Intervention Drug-Eluting Devices Report Years Considered
Figure Market Research Methodology
Figure Global Peripheral Intervention Drug-Eluting Devices Consumption Growth Rate 2013-2023 (K Units)
Figure Global Peripheral Intervention Drug-Eluting Devices Value Growth Rate 2013-2023 ($ Millions)
Table Peripheral Intervention Drug-Eluting Devices Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Plain Old Balloon Angioplasty (POBA)
Table Major Players of Plain Old Balloon Angioplasty (POBA)
Figure Product Picture of Percutaneous Transluminal Angioplasty (PTA)
Table Major Players of Percutaneous Transluminal Angioplasty (PTA)
Table Global Consumption Sales by Type (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type (2013-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2013-2018) ($ million)
Table Global Peripheral Intervention Drug-Eluting Devices Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Peripheral Intervention Drug-Eluting Devices Value Market Share by Type (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sale Price by Type (2013-2018)
Figure Peripheral Intervention Drug-Eluting Devices Consumed in Drug-Eluting Balloons
Figure Global Peripheral Intervention Drug-Eluting Devices Market: Drug-Eluting Balloons (2013-2018) (K Units)
Figure Global Peripheral Intervention Drug-Eluting Devices Market: Drug-Eluting Balloons (2013-2018) ($ Millions)
Figure Global Drug-Eluting Balloons YoY Growth ($ Millions)
Figure Peripheral Intervention Drug-Eluting Devices Consumed in Drug-Eluting Stents
Figure Global Peripheral Intervention Drug-Eluting Devices Market: Drug-Eluting Stents (2013-2018) (K Units)
Figure Global Peripheral Intervention Drug-Eluting Devices Market: Drug-Eluting Stents (2013-2018) ($ Millions)
Figure Global Drug-Eluting Stents YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2013-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Value by Application (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Value Market Share by Application (2013-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Value Market Share by Application (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sale Price by Application (2013-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Players (2016-2018) (K Units)
Table Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Players (2016-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Players in 2016
Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Players in 2017
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Players (2016-2018) ($ Millions)
Table Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Players (2016-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Players in 2016
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Players in 2017
Table Global Peripheral Intervention Drug-Eluting Devices Sale Price by Players (2016-2018)
Figure Global Peripheral Intervention Drug-Eluting Devices Sale Price by Players in 2017
Table Global Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution and Sales Area by Players
Table Players Peripheral Intervention Drug-Eluting Devices Products Offered
Table Peripheral Intervention Drug-Eluting Devices Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption by Regions 2013-2018 (K Units)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions 2013-2018
Figure Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions 2013-2018
Table Global Peripheral Intervention Drug-Eluting Devices Value by Regions 2013-2018 ($ Millions)
Table Global Peripheral Intervention Drug-Eluting Devices Value Market Share by Regions 2013-2018
Figure Global Peripheral Intervention Drug-Eluting Devices Value Market Share by Regions 2013-2018
Figure Americas Peripheral Intervention Drug-Eluting Devices Consumption 2013-2018 (K Units)
Figure Americas Peripheral Intervention Drug-Eluting Devices Value 2013-2018 ($ Millions)
Figure APAC Peripheral Intervention Drug-Eluting Devices Consumption 2013-2018 (K Units)
Figure APAC Peripheral Intervention Drug-Eluting Devices Value 2013-2018 ($ Millions)
Figure Europe Peripheral Intervention Drug-Eluting Devices Consumption 2013-2018 (K Units)
Figure Europe Peripheral Intervention Drug-Eluting Devices Value 2013-2018 ($ Millions)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption 2013-2018 (K Units)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Value 2013-2018 ($ Millions)
Table Americas Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018) (K Units)
Table Americas Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries (2013-2018)
Figure Americas Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2017
Table Americas Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018) ($ Millions)
Table Americas Peripheral Intervention Drug-Eluting Devices Value Market Share by Countries (2013-2018)
Figure Americas Peripheral Intervention Drug-Eluting Devices Value Market Share by Countries in 2017
Table Americas Peripheral Intervention Drug-Eluting Devices Consumption by Type (2013-2018) (K Units)
Table Americas Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type (2013-2018)
Figure Americas Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type in 2017
Table Americas Peripheral Intervention Drug-Eluting Devices Consumption by Application (2013-2018) (K Units)
Table Americas Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2013-2018)
Figure Americas Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2017
Figure United States Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure United States Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Canada Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Canada Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Table APAC Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018) (K Units)
Table APAC Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries (2013-2018)
Figure APAC Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2017
Table APAC Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018) ($ Millions)
Table APAC Peripheral Intervention Drug-Eluting Devices Value Market Share by Countries (2013-2018)
Figure APAC Peripheral Intervention Drug-Eluting Devices Value Market Share by Countries in 2017
Table APAC Peripheral Intervention Drug-Eluting Devices Consumption by Type (2013-2018) (K Units)
Table APAC Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type (2013-2018)
Figure APAC Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type in 2017
Table APAC Peripheral Intervention Drug-Eluting Devices Consumption by Application (2013-2018) (K Units)
Table APAC Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2013-2018)
Figure APAC Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2017
Figure China Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure China Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Japan Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Japan Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Korea Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Korea Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure India Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure India Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Australia Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Australia Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Table Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018) (K Units)
Table Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2017
Table Europe Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018) ($ Millions)
Table Europe Peripheral Intervention Drug-Eluting Devices Value Market Share by Countries (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Value Market Share by Countries in 2017
Table Europe Peripheral Intervention Drug-Eluting Devices Consumption by Type (2013-2018) (K Units)
Table Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type in 2017
Table Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application (2013-2018) (K Units)
Table Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2013-2018)
Figure Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2017
Figure Germany Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Germany Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure France Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure France Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure UK Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure UK Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Italy Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Italy Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Russia Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Russia Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Spain Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Spain Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2017
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Value Market Share by Countries in 2017
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Type in 2017
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2017
Figure Egypt Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Israel Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Israel Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure Turkey Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure Turkey Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Peripheral Intervention Drug-Eluting Devices Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Peripheral Intervention Drug-Eluting Devices Value Growth 2013-2018 ($ Millions)
Table Peripheral Intervention Drug-Eluting Devices Distributors List
Table Peripheral Intervention Drug-Eluting Devices Customer List
Figure Global Peripheral Intervention Drug-Eluting Devices Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Peripheral Intervention Drug-Eluting Devices Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption Market Forecast by Regions
Table Global Peripheral Intervention Drug-Eluting Devices Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Peripheral Intervention Drug-Eluting Devices Value Market Share Forecast by Regions
Figure Americas Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Americas Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure APAC Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure APAC Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Europe Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Europe Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure United States Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure United States Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Canada Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Canada Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Brazil Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Brazil Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure China Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure China Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Japan Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Japan Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Korea Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Korea Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure India Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure India Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Australia Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Australia Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Germany Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Germany Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure France Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure France Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure UK Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure UK Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Italy Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Italy Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Russia Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Russia Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Spain Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Spain Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Israel Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Israel Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure Turkey Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure Turkey Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Figure GCC Countries Peripheral Intervention Drug-Eluting Devices Consumption 2018-2023 (K Units)
Figure GCC Countries Peripheral Intervention Drug-Eluting Devices Value 2018-2023 ($ Millions)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Type (2018-2023) (K Units)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share Forecast by Type (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Value Forecast by Type (2018-2023) ($ Millions)
Table Global Peripheral Intervention Drug-Eluting Devices Value Market Share Forecast by Type (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Application (2018-2023) (K Units)
Table Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share Forecast by Application (2018-2023)
Table Global Peripheral Intervention Drug-Eluting Devices Value Forecast by Application (2018-2023) ($ Millions)
Table Global Peripheral Intervention Drug-Eluting Devices Value Market Share Forecast by Application (2018-2023)
Table Medtronic plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Medtronic plc Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)
Table Boston Scientific Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)
Table Cardinal Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Cardinal Health Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)
Table B. Braun Melsungen AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)
Table Biosensors International Group Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)
Table C.R. Bard, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)
Table St. Jude Medical, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)
Table The Lubrizol Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)
Table Terumo Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Terumo Corporation Peripheral Intervention Drug-Eluting Devices Market Share (2016-2018)


More Publications